Rhoda Alani

Affiliations: 
Johns Hopkins University, Baltimore, MD 
Area:
Molecular Biology, Cell Biology
Google:
"Rhoda Alani"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Waddell A, Grbic N, Leibowitz K, et al. (2024) p300 KAT regulates SOX10 stability and function in human melanoma. Biorxiv : the Preprint Server For Biology
Hanly A, Gibson F, Kuang K, et al. (2020) 692 Using a novel p300 HAT inhibitor as epigenetic therapy to treat BRAF inhibitor-resistant melanoma cells Journal of Investigative Dermatology. 140
Anastas JN, Zee BM, Kalin JH, et al. (2019) Re-programing Chromatin with a Bifunctional LSD1/HDAC Inhibitor Induces Therapeutic Differentiation in DIPG. Cancer Cell
Kim E, Zucconi BE, Wu M, et al. (2019) MITF Expression Predicts Therapeutic Vulnerability to p300 Inhibition in Human Melanoma. Cancer Research
Kida M, Falanga V, Wu M, et al. (2019) 941 Epigenetic manipulation of epidermal cells leads to enhanced cellular migration without an increase in cell proliferation Journal of Investigative Dermatology. 139: S162
Eisenstein A, Gonzalez EC, Raghunathan R, et al. (2018) Emerging Biomarkers in Cutaneous Melanoma. Molecular Diagnosis & Therapy
Hsu MY, Yang MH, Schnegg CI, et al. (2017) Notch3 signaling-mediated melanoma-endothelial crosstalk regulates melanoma stem-like cell homeostasis and niche morphogenesis. Laboratory Investigation; a Journal of Technical Methods and Pathology
Wu M, Kalin J, Ryu B, et al. (2017) Abstract 5068: A novel dual action inhibitor of histone deacetylase and demethylase in melanoma Cancer Research. 77: 5068-5068
Moriarty WF, Kim E, Gerber SA, et al. (2016) Neuropilin-2 promotes melanoma growth and progression in vivo. Melanoma Research
Moriarty WF, Kim E, Gerber SA, et al. (2016) Neuropilin-2 promotes melanoma growth and progression in vivo Melanoma Research
See more...